Plasma Protein Therapeutic Market Size

Plasma Protein Therapeutic Market Report By Type (Immunoglobulins, Albumin, Coagulation Factors, Alpha-1 Proteinase Inhibitor And Others), Application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026

ID:VMR11210720

January 2020

Report Formats:

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Description
Table Of Content

As per this study, the Global Plasma Protein Therapeutic Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.

Plasma protein therapeutic comprises of plasma-derived and recombinant analog therapies. These involve the treatment of various rare, life-threatening, chronic and genetic diseases. Some of the diseases that can be treated by using plasma protein therapeutic include bleeding disorders, immune deficiencies, pulmonary disorders, neurological disorders, shock and trauma, liver cirrhosis and infectious diseases such as tetanus, hepatitis, and rabies. Immunoglobulins, albumin, coagulation factors, and alpha-1 proteinase inhibitor are types of plasma protein therapeutic.

Market Dynamics

The increasing applications of plasma proteins in the pharmaceutical industry are driving market growth. Additionally, growing expenditure in the healthcare industry along with the introduction of new plasma-based therapies is further fuelling market growth. On the other hand, slower approval procedure and implementation of stringent regulation policies may restrict market growth. Whereas, increasing demand for plasma-based therapies in emerging economies is expected to create potential opportunity during the forecast period.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of plasma protein therapeutic.

Market Segmentation

The broad plasma protein therapeutic market has been sub-grouped into type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Type

Immunoglobulins
Albumin
Coagulation Factors
Alpha-1 proteinase inhibitor
Others

By Application

Hemophilia
Primary Immunodeficiency Disorder
Idiopathic Thrombocytopenic Purpura
Secondary Immunodeficiency
Others

Regional Analysis

Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for plasma protein therapeutic in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.

Europe Plasma Protein Therapeutic Market By Revenue (USD MN)

The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the plasma protein therapeutic market include Baxter, Biotest, Chengdu Inst., China Biologics, CSL Behring, Grifols, Kedrion, Octapharma, and Shire Plc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

METHODOLOGY:

A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Plasma Protein Therapeutic Market
       2.2. Global Plasma Protein Therapeutic Market Snapshot

3 . PLASMA PROTEIN THERAPEUTIC – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Plasma Protein Therapeutic Market
       3.3. Market Restraints of Plasma Protein Therapeutic Market
       3.4. Opportunities of Plasma Protein Therapeutic Market
       3.5. Trends of Plasma Protein Therapeutic Market
       3.6. Porter’s Five Force Analysis of Plasma Protein Therapeutic Market
       3.7. Plasma Protein Therapeutic Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Plasma Protein Therapeutic Value Chain Analysis
       4.2. Plasma Protein Therapeutic Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Plasma Protein Therapeutic Raw Material Manufactures List
           4.2.3. Price Trend of Plasma Protein Therapeutic Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET ANALYSIS BY TYPE
       5.1 Overview by Type
       5.2 Global Plasma Protein Therapeutic Market Analysis by Type
       5.3 Market Analysis of Immunoglobulins by Regions
       5.4 Market Analysis of Albumin by Regions
       5.5 Market Analysis of Coagulation Factors by Regions
       5.6 Market Analysis of Alpha-1 proteinase inhibitor by Regions
       5.7 Market Analysis of Others by Regions

6 . GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET ANALYSIS BY APPLICATION
       6.1 Overview by Application
       6.2 Global Plasma Protein Therapeutic Market Analysis by Application
       6.3 Market Analysis of Hemophilia by Regions
       6.4 Market Analysis of Primary Immunodeficiency Disorder by Regions
       6.5 Market Analysis of Idiopathic Thrombocytopenic Purpura by Regions
       6.6 Market Analysis of Secondary Immunodeficiency by Regions
       6.7 Market Analysis of Others by Regions

7 . GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Plasma Protein Therapeutic Market Estimate by Market Segment
           7.3.3. North America Plasma Protein Therapeutic Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
      7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Plasma Protein Therapeutic Market Estimate by Market Segment
           7.4.3. Europe Plasma Protein Therapeutic Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Plasma Protein Therapeutic Market Estimate by Market Segment
           7.5.3. Asia Pacific Plasma Protein Therapeutic Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Plasma Protein Therapeutic Market Estimate by Market Segment
           7.6.3. Latin America Plasma Protein Therapeutic Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Plasma Protein Therapeutic Market Estimate by Market Segment
           7.7.3. Middle East & Africa Plasma Protein Therapeutic Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa

8 . COMPETITIVE LANDSCAPE OF THE PLASMA PROTEIN THERAPEUTIC COMPANIES
       8.1. Plasma Protein Therapeutic Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments

9 . COMPANY PROFILES OF PLASMA PROTEIN THERAPEUTIC INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Baxter
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Biotest
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Chengdu Inst.
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. China Biologics
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. CSL Behring
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. Grifols
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Kedrion
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Octapharma
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Shire Plc.
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments

10. IMPACT ANALYSIS OF COVID-19 OUTBREAK
10.1. Impact Analysis of Covid-19 Outbreak on the Market
10.1.1. Direct Impact on Production
10.1.2. Supply Chain and Market Disruption
10.1.3. Financial Impact on Firms and Financial Markets
10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
10.3. Pre V/S Post COVID-19 Market
10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
10.5. COVID-19: Micro and Macro Factor Analysis on the Market

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Plasma Protein Therapeutic Report
Market Research Process
Market Research Methodology
Global Plasma Protein Therapeutic Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Type
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Plasma Protein Therapeutic Market Analysis by Type (USD MN)
Global Plasma Protein Therapeutic Market Analysis in Immunoglobulins by Geography (USD MN)
Global Plasma Protein Therapeutic Market Analysis in Albumin by Geography (USD MN)
Global Plasma Protein Therapeutic Market Analysis in Coagulation Factors by Geography (USD MN)
Global Plasma Protein Therapeutic Market Analysis in Alpha-1 proteinase inhibitor by Geography (USD MN)
Global Plasma Protein Therapeutic Market Analysis in Others by Geography (USD MN)
Global Plasma Protein Therapeutic Market Analysis by Application (USD MN)
Global Plasma Protein Therapeutic Market Analysis in Hemophilia by Geography (USD MN)
Global Plasma Protein Therapeutic Market Analysis in Primary Immunodeficiency Disorder by Geography (USD MN)
Global Plasma Protein Therapeutic Market Analysis in Idiopathic Thrombocytopenic Purpura by Geography (USD MN)
Global Plasma Protein Therapeutic Market Analysis in Secondary Immunodeficiency by Geography (USD MN)
Global Plasma Protein Therapeutic Market Analysis in Others by Geography (USD MN)
Latin America Plasma Protein Therapeutic Market by Revenue
Middle East & Africa Plasma Protein Therapeutic Market by Revenue
Recent Development in Plasma Protein Therapeutic Industry
Company Market Share Analysis, 2019

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "

ID:VMR11210720

January 2020

Report Formats:

Choose your Buying Option

Choose your Buying Option

Objectives of Study

Buy Chapters or Sections

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

Vincenzo Baydar – Head Planning, Leading Food Chain, US

Mia Tang, Director - Business Strategy, Steel Industry, Germany

Jo Chin, Owner of a Manufacturing Plant in Taiwan

Key questions answered by the report

Need specific market information?

ID:VMR11210720

January 2020

Report Formats:

Choose your Buying Option

Choose your Buying Option

Objectives of Study

Buy Chapters or Sections

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

Vincenzo Baydar – Head Planning, Leading Food Chain, US

Mia Tang, Director - Business Strategy, Steel Industry, Germany

Jo Chin, Owner of a Manufacturing Plant in Taiwan

Key questions answered by the report

Need specific market information?

Important: Covid19 pandemic market impact